1st Source Capital

1st Source Capital

1st Source Capital launched in 1979 as the private investment division of 1st Source Bank, a South Bend-headquartered institution that traces its roots to 1863. Unlike the dozen or so bank-owned SBICs that cycle through fund vintages, 1st Source Capital invests directly off the parent company's permanent capital base, a configuration that rewards patience over fund-life pressure. The firm operates out of Carmel, Indiana with additional investment offices in West Lafayette, Indianapolis, and Atlanta, a footprint that reflects its dual concentration on the Great Lakes manufacturing corridor and select Southeastern growth markets. The investment mandate spans two distinct pools. The private equity group pursues minority and control equity positions in companies generating $3 million to $15 million of EBITDA, typically alongside management teams rolling significant equity. The mezzanine and subordinated debt group provides junior capital to sponsor-backed transactions in the same lower-middle-market band, with check sizes between $2 million and $10 million per investment. Confirmed industry concentrations, per the firm's public communications, include contract pharmaceutical manufacturing, precision industrial components, healthcare services, and enterprise software platforms serving regulated end markets. The geographic emphasis remains heavily Midwestern, though the Atlanta office extends origination into the Southeast for both equity and debt mandates. Team-level granularity is thin in public filings — the parent bank does not break out dedicated investment headcount for the capital arm — but the unit carries a distinct credit culture inherited from the bank's conservative Midwestern underwriting tradition. The Atlanta expansion marked a recent operational move, adding Southeastern origination capacity without altering the core Indiana-centric governance structure. The firm's deals rarely surface in league tables because the equity positions are overwhelmingly minority stakes held for 5-to-8-year horizons, and the mezzanine book functions more like a proprietary credit portfolio than a fund product marketed to external LPs. What genuinely separates 1st Source Capital from the universe of bank-affiliated mezzanine shops is the permanent-capital base. There is no fund cycle, no LP redemption queue, and no artificial timeline to exit a performing credit or equity position. The architecture makes it a structurally patient counterparty for family-held manufacturers and founder-owned healthcare businesses that intend to sell a stake but not the whole company — precisely the kind of transaction that struggles to fit inside a standard 10-year private equity fund.